<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Humphrey Ralston | Activity</title>
	<link>https://www.catswannabecats.com/members/deadwheel24/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/deadwheel24/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Humphrey Ralston.</description>
	<lastBuildDate>Mon, 29 Jun 2026 10:35:48 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">688707d64e157430147e663252c37826</guid>
				<title>Humphrey Ralston posted an update: This represents a waste of resources and a loss of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23826/</link>
				<pubDate>Sun, 08 Jun 2025 10:40:45 -0400</pubDate>

									<content:encoded><![CDATA[<p>This represents a waste of resources and a loss of opportunity for other drugs to be properly evaluated. In the context of emergency, rigorous trials are more than ever needed in order to have, as soon as possible, reliable data on drugs that are possibly effective against the disease. Meanwhile, serious adverse drug reactions have been reported&hellip;<span class="activity-read-more" id="activity-read-more-23826"><a href="https://www.catswannabecats.com/activity/p/23826/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2bc8939b52fb3f1b9f9a8720536a889b</guid>
				<title>Humphrey Ralston posted an update: 36 h [12-60] for bowel sounds [P = 0.001], 48 h [12-108] vs. [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18782/</link>
				<pubDate>Wed, 04 Jun 2025 11:00:45 -0400</pubDate>

									<content:encoded><![CDATA[<p>36 h  for bowel sounds , 48 h  vs. 72 h  for passage of flatus , and 84 h  vs. 96  for passage of stools ). Perioperative complication rate (12 patients (44.4%) vs. 14 (51.9%), P = 0.786) was similar. Conclusions ERAS protocol leads to faster bowel recovery compared to conventional care in patients undergoing open RC but fails to demonstrate a&hellip;<span class="activity-read-more" id="activity-read-more-18782"><a href="https://www.catswannabecats.com/activity/p/18782/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1f392c97e984547f7312aa698d9929b3</guid>
				<title>Humphrey Ralston posted an update: Patients who received this combination therapy had a higher [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/3177/</link>
				<pubDate>Sat, 31 May 2025 10:14:30 -0400</pubDate>

									<content:encoded><![CDATA[<p>Patients who received this combination therapy had a higher grade ≥ 3 adverse event rate more than those who received AI monotherapy (Risk Difference 43%, 95%CI 0.39-0.47). Fulvestrant 500&nbsp;mg alone significantly improved PFS (risk ratio 0.85, 95%CI 0.72-0.98), but ORR and CBR were similar to those of anastrozole alone. CONCLUSION In the first&hellip;<span class="activity-read-more" id="activity-read-more-3177"><a href="https://www.catswannabecats.com/activity/p/3177/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">46a7583f0bbd26a91fc81573d916b088</guid>
				<title>Humphrey Ralston became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/3142/</link>
				<pubDate>Sat, 31 May 2025 10:07:18 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>